References
- Olesen J, Öberg G, Vestergaard P. Activities in the Danish Year of the Brain. Eur J Neurol 1997; 1998(5)619–24
- Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12 Suppl 1: 1–27
- Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe—A systematic review. Eur J Neurol 2005; 12: 245–53
- Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13: 700–22
- Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir. 2006; 148: 255–68
- Stovner LJ, Zwart J-A, Hagen K, Terwindt GM J. P. Epidemiology of headache in Europe. Eur J Neurol 2006; 13: 333–45
- Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: A review of available data. Eur J Neurol 2006; 13: 581–98
- Westphal M, Ekman M, Andlin-Sobocki P, Lönn S, Heese O. Brain tumor epidemiology in the European Union: A very critical review and quantified analysis. Acta Neurochirurgica. In press.
- Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005; 15: 357–76
- von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473–90
- Andlin-Sobocki P, Berg J, Ekman M, Jönsson B, Jönsson L, Kobelt G, et al. A review of European studies on the economic burden of brain diseases. Eur J Health Econ 2004; 12: S3–91
- Olesen J, Leonardi M. The burden of brain diseases in Europe. Eur J Neurol 2003; 10: 471–7
- Engberg AW, Teasdale T. Traumatic brain injury in Denmark 1979–96. A national study of incidence and mortality. Eur J Epidemiol 2001; 17: 437–42
- Joensen P. Prevalence, incidence, and classification of epilepsy in the Faroes. Acta Neurol Scand. 1986; 74: 150–5
- Koch-Henriksen N. The Danish Multiple Sclerosis Registry: A 50-year follow-up. Mult Scler. 1999; 5: 293–6
- Kraus L, Augustin R, Frischer M, Kummler P, Uhl A, Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 2003; 98: 471–485
- Olsen LR, Mortensen EL, Bech P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 2004; 109: 96–103
- Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population—A prevalence study. J Clin Epidemiol. 1991; 44: 1147–57
- Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995; 24: 612–8
- Truelsen T, Prescott E, Gronbaek M, Schnohr P, Boysen G. Trends in stroke incidence. The Copenhagen City Heart Study. Stroke. 1997; 28: 1903–7
- Andersen CK, Lauridsen J, Andersen K, Kragh-Sørensen P. Cost of dementia: Impact of disease progression estimated in longitudinal data. Scand J Public Health 2003; 31: 119–125
- Porsdal V, Boysen G. Costs of health care and social services during the first year after ischemic stroke. Int J Technol Assess Health Care. 1999; 15: 573–84
- Porsdal V, Boysen G. Direct costs of transient cerebral ischemia. A hospital-based study of resource use in Denmark during the first year following transient cerebral ischemic attack]. Ugeskr Laeger. 1999; 161: 6782–5
- Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A, et al. Comparing patterns and costs of schizophrenia care in five European countries: The EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Acta Psychiatr Scand 2002; 105: 42–54
- Rasmussen SR, Søgaard J. Socioeconomic costs due to tobacco smoking]. Ugeskr Laeger 2000; 162: 3329–33